Name: UMIN ID:
Unique ID issued by UMIN | UMIN000018440 |
---|---|
Receipt number | R000021348 |
Scientific Title | Prevention of atherosclerosis by SGLT2 inhibitor; multicenter, randomized controlled study |
Date of disclosure of the study information | 2015/07/31 |
Last modified on | 2023/01/30 10:46:31 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/07/27 17:09:01 | ||
2 | Update | 2015/08/05 10:52:34 | Blinding |
|
3 | Update | 2015/08/14 15:31:51 | Key secondary outcomes |
|
4 | Update | 2015/10/02 17:39:16 | Key secondary outcomes |
|
5 | Update | 2015/10/02 17:40:34 | Institutions |
|
6 | Update | 2015/11/18 09:32:45 | Institutions |
|
7 | Update | 2015/11/18 09:33:05 | Recruitment status |
|
8 | Update | 2015/12/18 13:04:49 | Institutions |
|
9 | Update | 2016/05/17 13:40:17 | Name of primary person or sponsor Organization Email1 |
|
10 | Update | 2016/06/06 17:21:34 | Randomization unit Key exclusion criteria Key exclusion criteria |
|
11 | Update | 2016/06/06 17:24:33 | Key secondary outcomes Key secondary outcomes |
|
12 | Update | 2016/06/06 17:30:28 | Institutions |
|
13 | Update | 2016/09/28 17:49:15 | Key inclusion criteria Key inclusion criteria |
|
14 | Update | 2016/12/02 17:32:52 | Institutions |
|
15 | Update | 2017/02/01 14:35:23 | Organization Organization |
|
16 | Update | 2017/05/24 13:53:13 | Institutions |
|
17 | Update | 2018/06/08 13:35:08 | Institutions |
|
18 | Update | 2018/06/15 10:57:27 | Recruitment status |
|
19 | Update | 2019/03/14 14:00:46 | UMIN ID1 |
|
20 | Update | 2019/03/15 11:28:53 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Division name Zip code Last name of contact person Last name of contact person Division name Zip code Name of person sending information Name of person sending information Organization Organization Division name Division name Address Address TEL Institute Department Organization Email1 Email3 Organization Organization Address Address Tel |
|
21 | Update | 2019/07/31 12:09:24 | Secondary IDs Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 |
|
22 | Update | 2020/07/30 09:41:09 | Number of participants that the trial has enrolled |
|
23 | Update | 2020/07/30 09:48:33 | Date of IRB Last follow-up date |
|
24 | Update | 2022/08/01 11:46:02 | Last follow-up date |
|
25 | Update | 2023/01/30 10:46:31 | Recruitment status |